Medicago

Quick facts

Marketed products

• Intramuscular injection
• Intramuscular vaccine

Phase 3 pipeline

• Fluarix Quadrivalent® Comparator Vaccine · Immunology
  Fluarix Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.
• Quadrivalent VLP Influenza Vaccine · Immunology / Infectious Disease
  A plant-based virus-like particle (VLP) vaccine that presents influenza surface antigens to stimulate immune responses against four influenza virus strains.
• Quadrivalent VLP Vaccine · Infectious Disease
  This quadrivalent VLP vaccine induces an immune response against four different strains of the influenza virus.

Phase 2 pipeline

• High dose of quadrivalent VLP vaccine
• Low dose of quadrivalent VLP vaccine
• Medium dose of quadrivalent VLP vaccine

Phase 1 pipeline

• Dose given at Day 0
• H5 VLP pandemic influenza vaccine 10 µg
• H5 VLP pandemic influenza vaccine 20 µg
• H5 VLP pandemic influenza vaccine 5 µg
• High dose of H7 VLP vaccine
• Instramuscular vaccine

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Medicago portfolio CI brief
• Medicago pipeline updates RSS